Asset
PBT-434
Alterity Therapeutics Limited American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05864365 | phase2 | completed | 2023-05-23 | 2025-02-26 | Alterity Therapeutics | A Biomarker Study of ATH434 in Participants With MSA |
| NCT07729852 | phase2 | not_yet_recruiting | 2026-07-01 | 2029-07-01 | Alterity Therapeutics | Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France |
FDA applications (0)
This company has no applications containing this asset.